Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
SYNTHON B V	6545 CM NIJMEGEN

International Classification(s)

• G01N:INVESTIGATING OR ANALYSING MATERIALS BY DETERMININ....

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Kolen, Sebastianus Martinus Henricus	Nijmegen, NL	1	0
# of filed Patents : 1 Total Citations : 0
Weijts, Francisca Antoinette Adriana	Nijmegen, NL	1	0
# of filed Patents : 1 Total Citations : 0

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• G01N Class

• 0 % this patent is cited more than
• 8 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Jan 11, 2025
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jan 11, 2029

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
July 11, 2017	US,9702866,B2   US9702866B2	GRANTED PATENT AS SECOND PUBLICATION
March 31, 2016	US,20160091486,A1   US20160091486A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9702866

Glatiramer acetate human monocytic cell line-based potency assay

---

Abstract

---

The present invention relates to a method to determine the potency of a batch of glatiramer acetate comprising stimulating human monocytic cell line cells with an effective amount of interferon (IFNγ), exposing the cells to a batch of glatiramer acetate, and determining the expression of the monocyte anti-inflammatory cytokine sIL-1Ra or the viability of the cells induced by glatiramer acetate.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• MAFP2025
• MAFP2020
• I2017
• STCF2017
• P2016
• F2014
• PD2013
• AS2013
• AS2013
• AS2013

Date	Code	Event	Description
Jan 01, 2025	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 8
Sep 22, 2020	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 4
Jul 11, 2017	I	Issuance
Jun 21, 2017	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Mar 31, 2016	P	Published
Apr 25, 2014	F	Filing
Apr 26, 2013	PD	Priority Date
Apr 25, 2013	AS	ASSIGNMENT	free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 038338 FRAME: 0041. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNORS:WEIJTS, FRANCISCA ANTOINETTE ADRIANA;KOLEN, SEBASTIANUS MARTINUS HENRICUS;REEL/FRAME:038642/0743 Owner name: SYNTHON B.V., NETHERLANDS Effective Date: Apr 25, 2013
Apr 25, 2013	AS	ASSIGNMENT	free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 037910 FRAME: 0217. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNORS:WEIJTS, FRANCISCA ANTIONETTE ADRIANA;KOLEN, SEBASTIANUS MARTINUS HENRICUS;REEL/FRAME:038338/0041 Owner name: SYNTHON B.V., NETHERLANDS Effective Date: Apr 25, 2013
Apr 25, 2013	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEIJTS, FRANCISCA ANTOINETTE ADRIANA;KOLEN, SEBASTIANUS MARTINUS HENRICUS;REEL/FRAME:037910/0217 Owner name: SYNTHON BIOPHARMACEUTICALS B.V., NETHERLANDS Effective Date: Apr 25, 2013